Funding for this research was provided by:
National Institutes of Health (R21-HG009010-01)
Text and Data Mining valid from 2019-05-20
Received: 19 December 2018
Accepted: 23 April 2019
First Online: 20 May 2019
: The authors declare no competing nonfinancial interests but do declare the following competing financial interests. Both S.S. and H.-C.C. hold some stock in AgenDx Biosciences Inc., a startup biotechnology company that has licensed some parts of the proposed integrated platform. S.S. and R.H. also serve as Scientific Consultants for AgenDx Biosciences Inc. and receive a consulting fee.